טוען...
A 12-Week Randomized Controlled Trial of Twice-Daily Intranasal Oxytocin for Social Cognitive Deficits in People with Schizophrenia
Social cognition is impaired in people with schizophrenia and these deficits are strongly correlated with social functioning. Oxytocin is a hypothalamic peptide that contributes to maternal infant bonding and has diverse pro-social effects in adults. This study tested the hypothesis that 12 weeks of...
שמור ב:
| הוצא לאור ב: | Schizophr Res |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5474129/ https://ncbi.nlm.nih.gov/pubmed/28094169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2017.01.008 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|